Join to View Full Profile
41 Mall RdBurlington, MA 01805
Phone+1 781-744-5100
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Tsoukas, MD is an internist in Burlington, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Certifications & Licensure
MA State Medical License 2013 - 2015
Clinical Trials
- Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting Start of enrollment: 2019 Feb 08
- Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin System Start of enrollment: 2020 Nov 02
Publications & Presentations
PubMed
- 19 citationsA fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.Michael A. Tsoukas, Dorsa Majdpour, Jean-François Yale, Anas El Fathi, Natasha Garfield
The Lancet. Digital Health. 2021-09-24 - 5 citationsStrategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy.Melissa-Rosina Pasqua, Michael A. Tsoukas, Ahmad Haidar
Journal of Diabetes Science and Technology. 2021-09-24 - 12 citationsAlleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studies.Michael A. Tsoukas, Elisa Cohen, Laurent Legault, Julia E. Von Oettingen, Jean-François Yale
Diabetes, Obesity & Metabolism. 2021-09-01
Press Mentions
Make It WorkFebruary 10th, 2025- Semaglutide Can Also Be Beneficial to People with Type 1 Diabetes, Clinical Trial FindsJanuary 15th, 2025
Grant Support
- Alleviating carbohydrate counting in adults with type 1 diabetes with weekly Semaglutide injections added to an automated insulin delivery with Lyumjev MCGILL UNIVERSITY HEALTH CTR RES INST2023–2026
